» Articles » PMID: 33187585

Lysine-Specific Demethylase 4A Regulates Osteogenic Differentiation Via Regulating the Binding Ability of H3K9me3 with the Promoters of Runx2, Osterix and Osteocalcin

Overview
Date 2020 Nov 14
PMID 33187585
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

A well-studied subject of epigenetics, the histone methylation located at lysine and arginine is overseen via methyltransferases and demethylases. Lysine-specific demethylase 4A (KDM4A) comprises a lysine demethylase and possesses specificity for H3K9me3 and H3K36me3, which is capable of being used in order to activate histone transcription. Our team examined the expression of KDM4A within Sprague Dawley (SD) rats and further investigated the mechanism via which this phenomena regulates osteogenic variation within the present study. The overexpression of KDM4A facilitated the process of osteoblast differentiation in bone mesenchymal stem cells (BMSC), while the knocking down differentiation via osteoblast was restrained via the suppression of the expression of Runx2, Osterix, alkaline phosphatase (ALP), and osteocalcin (OCN). Knocking down KDM4A lowered levels of the promoter expression of Runx2, osterix, and OCN, and raised levels of H3K27me3 expression. The results demonstrated that KDM4A possesses a crucial role within the differentiation of osteoblasts and furthermore regulates the expression of Runx2, Osterix, and OCN via H3K9me3. The present research may provide new insights into the treatment of bone healing.

Citing Articles

Differential gene expression of Wharton's jelly-derived mesenchymal cells mediated by graphene oxide in basal and osteo-induced media.

Hiew V, Teoh P Mol Biol Rep. 2024; 51(1):383.

PMID: 38433142 DOI: 10.1007/s11033-024-09324-9.


The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities.

Yang G, Li C, Tao F, Liu Y, Zhu M, Du Y Genes Dis. 2023; 11(2):645-663.

PMID: 37692513 PMC: 10491877. DOI: 10.1016/j.gendis.2022.12.020.


Dysregulation of histone modifications in bone marrow mesenchymal stem cells during skeletal ageing: roles and therapeutic prospects.

Li Y, Hu M, Xie J, Li S, Dai L Stem Cell Res Ther. 2023; 14(1):166.

PMID: 37357311 PMC: 10291799. DOI: 10.1186/s13287-023-03393-6.


Epigenetic control of mesenchymal stem cells orchestrates bone regeneration.

Wang X, Yu F, Ye L Front Endocrinol (Lausanne). 2023; 14:1126787.

PMID: 36950693 PMC: 10025550. DOI: 10.3389/fendo.2023.1126787.


Atf7ip Inhibits Osteoblast Differentiation via Negative Regulation of the Sp7 Transcription Factor.

Hu G, Shi X, Qu X, Han C, Hu A, Jia Z Int J Mol Sci. 2023; 24(5).

PMID: 36901736 PMC: 10002255. DOI: 10.3390/ijms24054305.